Glycopyrrolate
Product Images NDC 55154-8225

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 55154-8225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag Label (3172b316 80f5 4891 B9f2 0f9535fd928a 00)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL, in a package containing 5 single-dose 1 mL vials. The label includes usage instructions indicating intramuscular or intravenous use, a warning against use in newborns, storage conditions, and manufacturing and distribution information. Manufactured by Amneal Pharmaceuticals Pvt. Ltd., India, and distributed by Cardinal Health 107, LLC.*

FDA Label Image

Structure (Glycopyrrolate Injection Usp 1)

Chemical structure of the active ingredient Glycopyrrolate, showing its molecular arrangement including a cyclopentyl group, hydroxyl group, and a quaternary ammonium moiety with a bromide counterion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.